Fiscal Year 2019 (Ending May 31, 2019)-Projected
Fiscal year 2019 is shaping up to be another solid year. As of February 28, 2019, we anticipate that core operations will end the fiscal year slightly better than budget (Figure 1 ). The financial performance of the program development and capital budget, building sale reserve funds, and building fund will ultimately depend on our fiscal year investment returns, which are trending in a favorable direction.
A significant accomplishment during fiscal year 2019 is growing ASHP's total membership to nearly 49,500 members as of December 31, 2018, which is a 10% increase from the prior year. With your continued involvement and support, we can collectively advance the roles and impact of pharmacy services across the continuum of care.
Fiscal Year 2020 (Ending May 31, 2020)-Budget ASHP's core operations budget for fiscal year 2020 is balanced (Figure 1 ). Core gross revenue is projected to increase to $54.2 million. The program development and capital budget and building sale reserve funds have budgeted surpluses of $175,000 and $185,000, respectively. Reserves/net assets spending is budgeted at $200,000 for the depreciation of previously purchased assets. Although the building fund has a budgeted accrual accounting loss of $416,000, primarily related to depreciation, it is budgeted to have positive cash flow for fiscal year 2020 and continues to be on track to achieve its long-term financial target.
Wisconsin Building Corporation
ASHP's subsidiary, the 7272 Wisconsin Building Corporation, owned ASHP's previous headquarters building in Bethesda, Maryland, and derived income from leased commercial and office space that was used to support ASHP's expansive membership mission. We anticipate this subsidiary will be closed by the middle of calendar year 2019.
Investments and Growth in ASHP
Due to our strong financial position, we are pleased to have had the resources to invest in new initiatives to better serve our members and the profession. ASHP has developed the Pharmacy Technician Forum and the Section of Specialty Pharmacy Practitioners to better support member needs in those areas. ASHP has also further developed specialty pharmacy accreditation, enhanced our pharmacy residency and technician accreditation management systems, joined the National Academy of Medicine Collaborative on Clinician Well-Being and Resilience, and developed additional certification and certificate products. In addition, ASHP has supported Board of Pharmacy Specialties petitions for sterile compounding, solid organ transplant, and emergency medicine specialties. There have also been investments to enhance the ASHP website and upgrade ASHP's financial accounting and reporting systems. The staff and Board of Directors of ASHP continue to actively look to the future and invest in programs and services that support our members in advancing the profession of pharmacy.
Conclusion
The ASHP Board of Directors, CEO, and staff remain committed to supporting, you-our members-and advancing the profession of pharmacy. We are proud to have nearly 50,000 members and to be at the forefront of improving medication use and enhancing patient safety. ASHP's financial strength and diversity of revenue sources allows for continued investment and development of a wide variety of member services, including educational resources, advocacy resources, and advancement of membership sections and forums. ASHP is positioned for the long term to continue to advance the profession and positively impact pharmacy services to fulfill our Mission and Vision.
It is hard to believe my 3-year term as ASHP Treasurer comes to an end in August 2019. It has been a pleasure and an honor serving as your Treasurer. I continue to be truly amazed at the outstanding work by ASHP members in so many diverse practice areas. And thank you to everyone that continues to move our profession forward to make a difference in the lives and health of our patients.
